Sonoma Pharmaceuticals, Inc.
SNOA
$1.33
$0.010.38%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 36.32% | 8.16% | 10.09% | 5.62% | 22.04% |
| Total Depreciation and Amortization | 0.00% | 0.72% | -7.43% | -15.00% | -20.59% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -154.91% | -165.03% | -82.26% | -64.20% | -65.81% |
| Change in Net Operating Assets | -116.68% | -116.40% | -110.91% | -34.54% | 160.58% |
| Cash from Operations | -115.53% | -4,369.32% | -2,306.92% | -44.37% | 61.52% |
| Capital Expenditure | 51.38% | -140.00% | -1,300.00% | -1,078.57% | -1,910.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 51.38% | -140.00% | -1,300.00% | -1,078.57% | -1,910.00% |
| Total Debt Issued | 1.09% | 1.09% | -26.54% | -26.54% | -26.54% |
| Total Debt Repaid | 25.68% | 32.92% | 27.82% | 29.37% | 22.13% |
| Issuance of Common Stock | 64.02% | -85.10% | -89.61% | -78.49% | -4.33% |
| Repurchase of Common Stock | -- | -- | 100.00% | 100.00% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 70.76% | -84.26% | -90.26% | -79.35% | -4.54% |
| Foreign Exchange rate Adjustments | 667.31% | 209.25% | 198.34% | 185.05% | 116.40% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 70.57% | -232.46% | -194.52% | -153.74% | 206.39% |